Cite Filings / ZNTL / 0001950047-23-001083
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Zentalis Pharmaceuticals, Inc. · Filed 2023-05-31 · Acc 0001950047-23-001083

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2023-09-11 144 Sale of Securities
  • 2023-06-05 8-K Regulation FD disclosure · Other events
  • 2023-05-31 144 Sale of Securities
  • 2023-05-31 144 Sale of Securities
  • 2023-05-31 4 President sold 27,768 shares at an average $26.27 ($729,506)
  • 2023-05-31 4 Chief Scientific Officer sold 80,000 shares at $30.02 ($2,401,248)
  • 2023-05-26 8-K Regulation FD disclosure · Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…